Overview

Immune repertoire sequencing market is poised to value USD 199 million by 2028 end at a CAGR of 7.3% during the forecast period 2022 to 2028.

Immune repertoire describes the sub-types of proteins that the immune system of an organism produces. Six essential protein types make up the immune systems of vertebrates: two immunoglobulin and four T cell receptors. Researchers and scientists can analyse and comprehend diseases caused by adaptive immune systems thanks to immune repertoire sequencing. Immune repertoire sequencing has broad applications in the discovery of biomarkers, the study of infectious diseases, the study of asthma and allergies, and the study of cancer immunotherapy. To increase the efficiency and cost-effectiveness of rational medication development, immune repertoire sequencing is widely used in biomarker discovery. T cell receptor-beta sequencing services are now available through the Center for Commercialization of Cancer Immunotherapy (C3iBiomarker )'s and Diagnostic unit. Immune repertoire sequencing is helpful in locating the specific antigen information contained in lymphocytes and in comprehending the body's defences against intruders. Immune repertoire sequencing is used for a variety of purposes, such as the discovery of biomarkers, cancer immunotherapy, the investigation of allergies and asthma, and the study of infectious diseases. The usage of immune repertoire sequencing is growing as a result of an increase in the number of novel product launches, product development R&D, and cancer patients. The market's growth will be fueled by these elements as well as increasing government backing. Numerous organisations will keep looking for solutions for immune system biomarkers during the projected period in an effort to create new opportunities for the immunological repertoire sequencing market. The market for immune repertoire sequencing is anticipated to develop as a result of rising demand for customised medicine, which analyses a person's genetic profile to inform decisions about the diagnosis, prevention, and treatment of illnesses.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Immune Repertoire Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Immune Repertoire Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Prominent players of the market are:

ABVITRO (NOW JUNO THERAPEUTICS), ADAPTIVE BIOTECHNOLOGIES, AGILENT TECHNOLOGIES, ARCHERDX, INC., BGI, ILLUMINA, INC., IREPERTOIRE, INC., OXFORD NANOPORE TECHNOLOGIES, LTD, PACIFIC BIOSCIENCES, Qiagen N.V., Takara Bio Inc., CD Genomics, Roche Holding AG  and Thermo Fisher Scientific

Immune Repertoire Sequencing Market Segmentation: 

By Product

• Instrument
  o NGS
  o PCR
• Assay, Kits and Reagent
  o TCR Kits
    • Human TCR Kits
    • Mouse TCR Kits
  o BCR Kits
    • Human BCR Kits
    • Mouse BCR Kits
• Analytical Software
  o TCR Analysis Solutions
  o BCR Analysis Solutions
  o TCR & BCR Analysis Solutions
• Services
  o Pre-Sequencing Services
  o Sequencing Services
  o Data Analysis Services

By Application

  • Biomarker Discovery
  • Autoimmune Diseases
  • Cancer Immunotherapy
  • Infectious Disease Research
  • Asthma and Allergy Research
  • Vaccine Development
  • Immunodeficiency Identification
  • Others (If Any)

By End User

  • Diagnostic Labs
  • Pharmaceutical and Biotech Companies
  • Research Institutes
  • Others (If Any)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America 
  • Middle East and Africa 

Immune Repertoire Sequencing Market Sample Video:

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major market share  
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants   

FutureWise Takeaways: 
•    Growth prospects  
•    SWOT analysis 
•    Key trends 
•    Key data points affecting market growth  

Objectives of the Study: 
•    To provide with an exhaustive analysis on the immune repertoire sequencing market based on by products, by application, by end users and by region 
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) 
•    To evaluate and forecast micro-markets and the overall market  
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

Flexible Delivery Model

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics